Protara Therapeutics, Inc.TARANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-56.37M
↓ 89% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-29.90M
Historical baseline
PeriodValueYoY Change
2025$-56.37M-57.4%
2024$-35.81M+4.7%
2023$-37.56M-42.0%
2022$-26.46M+23.3%
2021$-34.50M-47.4%
2020$-23.41M-49.6%
2019$-15.65M+32.7%
2018$-23.23M-3.9%
2017$-22.35M+5.6%
2016$-23.69M-